Fig. 4From: Towards personalised dosimetry in patients with liver malignancy treated with 90Y-SIRT using in vivo-driven radiobiological parametersThe BED map for lesions shown in Fig. 3. a–c The \({\text{BED}}_{\infty }\) and \({\text{BED}}_{exp}\) maps for lesion 1 (L1) and lesion 2 (L2) with the zoom-in of the lesion BED maps. d The \({\text{BED}}_{\infty }\) and \({\text{BED}}_{{{\text{exp}}}}\) volume histograms for both lesionsBack to article page